These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18398304)

  • 1. Functional activity of antisera to group B streptococcal conjugate vaccines measured with an opsonophagocytosis assay and HL-60 effector cells.
    Guttormsen HK; Liu Y; Paoletti LC
    Hum Vaccin; 2008; 4(5):370-4. PubMed ID: 18398304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus.
    Fabbrini M; Sammicheli C; Margarit I; Maione D; Grandi G; Giuliani MM; Mori E; Nuti S
    J Immunol Methods; 2012 Apr; 378(1-2):11-9. PubMed ID: 22309986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescence-based opsonophagocytosis assay to measure the functional activity of antibody to group B Streptococcus.
    Guttormsen HK; Mascuch SJ; West JC; Paoletti LC
    Hum Vaccin; 2009 Jul; 5(7):461-6. PubMed ID: 19377284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.
    Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Edwards MS; Kasper DL
    J Infect Dis; 2004 Mar; 189(6):1103-12. PubMed ID: 14999615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
    Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
    Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.
    Yang HH; Mascuch SJ; Madoff LC; Paoletti LC
    Clin Vaccine Immunol; 2008 Jul; 15(7):1035-41. PubMed ID: 18463225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
    Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
    Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
    Hillier SL; Ferrieri P; Edwards MS; Ewell M; Ferris D; Fine P; Carey V; Meyn L; Hoagland D; Kasper DL; Paoletti LC; Hill H; Baker CJ
    Clin Infect Dis; 2019 May; 68(12):2079-2086. PubMed ID: 30281066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation.
    Pannaraj PS; Edwards MS; Ewing KT; Lewis AL; Rench MA; Baker CJ
    Vaccine; 2009 Jul; 27(33):4452-6. PubMed ID: 19490960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine.
    Baker CJ; Rench MA; McInnes P
    Vaccine; 2003 Jul; 21(24):3468-72. PubMed ID: 12850362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines.
    Paoletti LC; Rench MA; Kasper DL; Molrine D; Ambrosino D; Baker CJ
    Infect Immun; 2001 Nov; 69(11):6696-701. PubMed ID: 11598040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoconjugate vaccines to prevent group B streptococcal infections.
    Paoletti LC; Kasper DL
    Expert Opin Biol Ther; 2003 Sep; 3(6):975-84. PubMed ID: 12943456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen.
    Paoletti LC; Peterson DL; Legmann R; Collier RJ
    Vaccine; 2001 Nov; 20(3-4):370-6. PubMed ID: 11672899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant fragments of conservative proteins of group B streptococci as a basis of specific vaccine].
    Suvorov AN; Grabovskaia KB; Leont'eva GF; Meringova LF; Koroleva IN; Duplik NV; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):44-50. PubMed ID: 20465000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines.
    Edwards MS; Lane HJ; Hillier SL; Rench MA; Baker CJ
    Vaccine; 2012 Jun; 30(28):4123-6. PubMed ID: 22537994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of experimental conjugated and combined vaccines against group B streptococci].
    Ditina MA; Meringova LF; Leont'eva GF; Frabovskaia KB; Yang A; Shen Z; Suvorov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):37-41. PubMed ID: 19338234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
    Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Rodewald AK; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1993 Nov; 61(11):4760-6. PubMed ID: 8406875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.